Ownership history in Bleichroeder LP · 25 quarters on record
This page tracks every 13F SEC filing in which Bleichroeder LP reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 6,819,164 | — | 0% | 0.37% | $2.1M | $0.31 |
| 2025 Q3 | UNCHANGED | 6,819,164 | — | 0% | 0.96% | $4.9M | $0.72 |
| 2025 Q2 | ADDED | 6,819,164 | +1,821,924 | +36.5% | 1.14% | $4.7M | $0.68 |
| 2025 Q1 | UNCHANGED | 4,997,240 | — | 0% | 1.21% | $4.6M | $0.91 |
| 2024 Q4 | UNCHANGED | 4,997,240 | — | 0% | 1.37% | $5.4M | $1.09 |
| 2024 Q3 | ADDED | 4,997,240 | +2,135,634 | +74.6% | 1.02% | $3.8M | $0.76 |
| 2024 Q2 | ADDED | 2,861,606 | +106,578 | +3.9% | 1.06% | $3.5M | $1.24 |
| 2024 Q1 | ADDED | 2,755,028 | +1,000,000 | +57.0% | 1.30% | $5.2M | $1.89 |
| 2023 Q4 | ADDED | 1,755,028 | +1,000,000 | +132.4% | 1.03% | $4.6M | $2.64 |
| 2023 Q3 | UNCHANGED | 755,028 | — | 0% | 0.43% | $1.7M | $2.30 |
As of 2025 Q4 — sorted by position size